Expion360 Inc.
Expion360 Inc. (XPON) Financial Performance & Income Statement Overview
Explore the financials of Expion360 Inc. (XPON), including yearly and quarterly data on income, cash flow, and balance sheets.
Expion360 Inc. (XPON) Income Statement & Financial Overview
Review Expion360 Inc. XPON income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.99M | $1.39M | $1.28M | $971859.00 |
| Cost of Revenue | $1.55M | $1.22M | $952646.00 | $794116.00 |
| Gross Profit | $438552.00 | $168691.00 | $325463.00 | $177743.00 |
| Gross Profit Ratio | $0.22 | $0.12 | $0.25 | $0.18 |
| R&D Expenses | $66510.00 | $68617.00 | $84663.00 | $75502.00 |
| SG&A Expenses | $1.52M | $1.99M | $1.88M | $2.07M |
| Operating Expenses | $1.62M | $2.10M | $2.004M | $2.14M |
| Total Costs & Expenses | -$3.17M | $3.32M | $2.96M | $2.94M |
| Interest Income | $26072.00 | $14589.00 | $18596.00 | $26865.00 |
| Interest Expense | $5057.00 | $467715.00 | $250560.00 | $253286.00 |
| Depreciation & Amortization | $34097.00 | $45010.00 | $45422.00 | $49444.00 |
| EBITDA | -$215416.00 | -$8.30M | -$1.92M | -$1.89M |
| EBITDA Ratio | -$0.11 | -$5.97 | -$1.51 | -$1.94 |
| Operating Income | -$1.18M | -$1.93M | -$1.68M | -$1.97M |
| Operating Income Ratio | -$0.59 | -$1.39 | -$1.31 | -$2.02 |
| Other Income/Expenses (Net) | $925891.00 | -$6.89M | -$540975.00 | -$225527.00 |
| Income Before Tax | -$254574.00 | -$8.81M | -$2.22M | -$2.19M |
| Income Before Tax Ratio | -$0.13 | -$6.34 | -$1.74 | -$2.26 |
| Income Tax Expense | -$2927.00 | $460.00 | $460.00 | $460.00 |
| Net Income | -$251647.00 | -$8.81M | -$2.22M | -$2.19M |
| Net Income Ratio | -$0.13 | -$6.34 | -$1.74 | -$2.26 |
| EPS | -$0.39 | -$24.55 | -$0.30 | -$0.31 |
| Diluted EPS | -$0.39 | -$24.55 | -$0.30 | -$0.31 |
| Weighted Avg Shares Outstanding | $2.10M | $358990.00 | $7.36M | $7.006M |
| Weighted Avg Shares Outstanding (Diluted) | $2.10M | $358990.00 | $7.36M | $7.006M |
The company's financials show resilient growth, with revenue advancing from $971859.00 in Q1 2024 to $1.99M in Q4 2024. Gross profit remained healthy with margins at 22% in Q4 2024 compared to 18% in Q1 2024. Operating income hit -$1.18M last quarter, sustaining a consistent -59% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$215416.00. Net income rose to -$251647.00, while earnings per share reached -$0.39. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan